Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Ethan V. Abel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-2922-617X; OpenAlex author ID A5029464243; NIH RePORTER profile ID 12498487. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 2)
Trials
0
Grants
2
Labs led
1
Collaborators
36
Papers, trials and grants by year

2013: 2 papers · 2014: 2 papers · 2015: none · 2016: 1 paper, 1 grant · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper, 1 grant

Papers 11

  1. HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma Last author DOI 10.1038/s42003-026-10685-z↗
  2. Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12943-025-02408-5↗
  3. The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-23-2504↗
  4. ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer. Co-author DOI 10.1101/gad.344184.120↗
  5. Beta 1 integrin signaling mediates pancreatic ductal adenocarcinoma resistance to MEK inhibition. Co-author DOI 10.1038/s41598-020-67814-9↗
  6. HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties. Co-author DOI 10.7554/elife.33947↗
  7. GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-15-0947↗
  8. Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-14-1269↗
  9. The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0091983↗
  10. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Co-author DOI 10.1038/oncsis.2013.23↗
  11. Biology and clinical applications of pancreatic cancer stem cells. Co-author DOI 10.1053/j.gastro.2013.01.072↗

Grants 2

  1. Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma R37CA275961↗
  2. Pathway to Leadership Grant: Ethan Abel (HNF1A in pancreatic cancer cells) AWARD pancan:2016-ethan-abel-phd-pathway-to-leadership-grant-ethan-abel-h

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Erik S. Knudsen · 3 shared papers, 2024–2026 · strength 0.72
  2. Agnieszka Katarzyna Witkiewicz · 3 shared papers, 2024–2026 · strength 0.72
  3. Kennedy S. Humphrey · 2 shared papers, 2025–2026 · strength 0.51
  4. Katherine J. Crawford · 2 shared papers, 2025–2026 · strength 0.51
  5. Vishnu Muthuraj Kumarasamy · 2 shared papers, 2024–2025 · strength 0.44
  6. Diane M. Simeone · 7 shared papers, 2013–2021 · strength 0.41
  7. Howard C. Crawford · 3 shared papers, 2018–2021 · strength 0.29
  8. Marina Pasca di Magliano · 3 shared papers, 2016–2021 · strength 0.28
  9. Michael E. Feigin · 1 shared paper, 2025 · strength 0.23
  10. Karen M. Mann · 1 shared paper, 2025 · strength 0.23
  11. Prasenjit Dey · 1 shared paper, 2024 · strength 0.21
  12. Arthur Lee Brannon · 1 shared paper, 2020 · strength 0.13
  13. Nina G. Steele · 1 shared paper, 2020 · strength 0.13
  14. Donovan Drouillard · 1 shared paper, 2020 · strength 0.13
  15. Meghna Waghray · 2 shared papers, 2016–2018 · strength 0.11
  16. Vinee Purohit · 1 shared paper, 2021 · strength 0.10
  17. Thales Y. Papagiannakopoulos · 1 shared paper, 2021 · strength 0.10
  18. Lidong Wang · 1 shared paper, 2021 · strength 0.10
  19. Costas Andreas Lyssiotis · 1 shared paper, 2021 · strength 0.10
  20. Vaibhav Sahai · 2 shared papers, 2014–2016 · strength 0.09
  21. Edward Jae-Hoon Kim · 2 shared papers, 2014 · strength 0.08
  22. Mats E. Ljungman · 1 shared paper, 2018 · strength 0.07
  23. Jiaqi Shi · 1 shared paper, 2018 · strength 0.07
  24. Chandan Kumar‐Sinha · 1 shared paper, 2018 · strength 0.07
  25. Mina Zeinali · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.